Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Bsteh

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Journal of Central Nervous System Disease|May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational studyChristoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum hepcidin levels in multiple sclerosisGabriel Bsteh, David Haschka, Piotr Tymoszuk, et al.
Frontiers in Immunology|November 5, 2021
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an AssociationFranziska Di Pauli, Paul Morschewsky, Klaus Berek, et al.
Neurology|August 2, 2022
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple SclerosisGabriel Bsteh, Nik Krajnc, Katharina Riedl, et al.
European Journal of Neurology|March 18, 2021
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
JMIR Research Protocols|May 7, 2021
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot StudyPatrick Altmann, Werner Hinterberger, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosisKlaus Berek, Harald Hegen, Jakob Hocher, et al.
Brain and Behavior|November 18, 2024
Neurofilament Light Chain Is Associated With Acute Mountain SicknessKlaus Berek, Anna Lindner, Franziska Di Pauli, et al.
Multiple Sclerosis and Related Disorders|December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosisGabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 15, 2023
Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosisNik Krajnc, Victor Schmidbauer, Joel Leinkauf, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Journal of Central Nervous System Disease|May 7, 2024
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational studyChristoph Friedli, Nik Krajnc, Helly N Hammer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum hepcidin levels in multiple sclerosisGabriel Bsteh, David Haschka, Piotr Tymoszuk, et al.
Frontiers in Immunology|November 5, 2021
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an AssociationFranziska Di Pauli, Paul Morschewsky, Klaus Berek, et al.
Neurology|August 2, 2022
Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple SclerosisGabriel Bsteh, Nik Krajnc, Katharina Riedl, et al.
European Journal of Neurology|March 18, 2021
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
JMIR Research Protocols|May 7, 2021
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot StudyPatrick Altmann, Werner Hinterberger, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosisKlaus Berek, Harald Hegen, Jakob Hocher, et al.
Brain and Behavior|November 18, 2024
Neurofilament Light Chain Is Associated With Acute Mountain SicknessKlaus Berek, Anna Lindner, Franziska Di Pauli, et al.
Multiple Sclerosis and Related Disorders|December 11, 2024
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosisGabriel Bsteh, Stefanie Marti, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 15, 2023
Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosisNik Krajnc, Victor Schmidbauer, Joel Leinkauf, et al.
Pageof 17